These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8931867)
1. Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice. Sato H; Sugimoto I; Matsunaga T; Tsuchimoto M; Ohta T; Uno H; Kiyoki M Arch Dermatol Res; 1996 Oct; 288(11):656-63. PubMed ID: 8931867 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological profiles of high-concentration (20 microg/g) tacalcitol ointment: effects on cutaneous inflammation, epidermal proliferation, and differentiation in mice. Sato H; Ogino Y; Takagi H; Hata J; Asano S; Ohta T; Komoriya K J Dermatol; 2003 Jul; 30(7):510-24. PubMed ID: 12928540 [TBL] [Abstract][Full Text] [Related]
3. The effect of 1,24(R)(OH)2D3 cream and ointment on epidermal proliferation and differentiation in mice. Sato H; Sugimoto I; Fukuoka M; Ohta T; Kiyoki M Dermatology; 1996; 192(3):233-8. PubMed ID: 8726637 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of tacalcitol (1,24(R)(OH)2D3, TV-02) in the skin of TPA-treated hairless mice. Sato H; Nakayama Y; Yamashita C; Uno H J Dermatol; 2004 Mar; 31(3):200-17. PubMed ID: 15187340 [TBL] [Abstract][Full Text] [Related]
5. Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis. Gupta AK; Fisher GJ; Elder JT; Talwar HS; Esmann J; Duell EA; Nickoloff BJ; Voorhees JJ J Invest Dermatol; 1989 Sep; 93(3):379-86. PubMed ID: 2570112 [TBL] [Abstract][Full Text] [Related]
6. Sphingosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity, and activation of protein kinase C in mouse skin. Gupta AK; Fisher GJ; Elder JT; Nickoloff BJ; Voorhees JJ J Invest Dermatol; 1988 Nov; 91(5):486-91. PubMed ID: 3171222 [TBL] [Abstract][Full Text] [Related]
7. The effect of long-term treatment with tacalcitol on the psoriatic epidermis. A flow cytometric analysis. Mommers JM; Castelijns FA; Seegers BA; Van Rossum MM; Van Hooijdonk CA; Van Erp PE; Van De Kerkhof PC Br J Dermatol; 1998 Sep; 139(3):468-71. PubMed ID: 9767292 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of phorbol ester-caused synthesis of mouse epidermal ornithine decarboxylase by retinoic acid. Verma AK Biochim Biophys Acta; 1985 Jul; 846(1):109-19. PubMed ID: 2861859 [TBL] [Abstract][Full Text] [Related]
9. Topical vitamin D3 derivatives impair the epidermal permeability barrier in normal mouse skin. von Brenken S; Jensen JM; Fartasch M; Proksch E Dermatology; 1997; 194(2):151-6. PubMed ID: 9094464 [TBL] [Abstract][Full Text] [Related]
10. Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro. Gschwendt M; Fürstenberger G; Rose-John S; Rogers M; Kittstein W; Pettit GR; Herald CL; Marks F Carcinogenesis; 1988 Apr; 9(4):555-62. PubMed ID: 2451575 [TBL] [Abstract][Full Text] [Related]
11. Induction of mouse epidermal ornithine decarboxylase activity and skin tumors by 7,12-dimethylben. Verma AK; Conrad EA; Boutwell RK Carcinogenesis; 1980 Jul; 1(7):607-11. PubMed ID: 11219836 [TBL] [Abstract][Full Text] [Related]
12. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation. Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313 [TBL] [Abstract][Full Text] [Related]
13. Influence of tacalcitol on cell cycle kinetics of human keratinocytes following standardized injury. Mommers JM; ter Meulen AC; van Erp PE; van de Kerkhof PC Skin Pharmacol Appl Skin Physiol; 1999; 12(4):174-81. PubMed ID: 10420137 [TBL] [Abstract][Full Text] [Related]
14. Palmitoylcarnitine reverses 12-O-tetradecanoylphorbol-13-acetate-induced refractory state for the TPA-caused ornithine decarboxylase induction in mouse epidermis. Aizu E; Yamamoto S; Nakadate T; Kiyoto I; Kato R Carcinogenesis; 1988 Feb; 9(2):309-13. PubMed ID: 3338115 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin ornithine decarboxylase and protein kinase C by polyphenolics from grapes. Bomser J; Singletary K; Meline B Chem Biol Interact; 2000 Jun; 127(1):45-59. PubMed ID: 10903418 [TBL] [Abstract][Full Text] [Related]
16. Dissociation of tumour-promoter-induced effects on prostaglandin release, polyamine synthesis and cell proliferation of 3T3 cells. Lanz R; Brune K Biochem J; 1981 Mar; 194(3):975-82. PubMed ID: 7306036 [TBL] [Abstract][Full Text] [Related]
17. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Gerritsen MJ; Boezeman JB; van Vlijmen-Willems IM; Van de Kerkhof PC Br J Dermatol; 1994 Jul; 131(1):57-63. PubMed ID: 7519032 [TBL] [Abstract][Full Text] [Related]
18. The induction of epidermal transglutaminase and terminal differentiation by tumor promoters in cultured epidermal cells. Yuspa SH; Ben T; Hennings H Carcinogenesis; 1983 Nov; 4(11):1413-8. PubMed ID: 6139180 [TBL] [Abstract][Full Text] [Related]
19. Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin. Kim S; Hong I; Hwang JS; Choi JK; Rho HS; Kim DH; Chang I; Lee SH; Lee MO; Hwang JS Mol Med; 2006; 12(1-3):17-24. PubMed ID: 16838068 [TBL] [Abstract][Full Text] [Related]
20. Initiator and promoter induced specific changes in epidermal function and biological potential. Yuspa SH; Hennings H; Lichti U J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]